NCT01823133View on ClinicalTrials.gov

Study for Investigate the Pharmacokinetic Drug Interactions Between Gemigliptin and Rosuvastatin

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

May 31, 2013

Study Completion Date

August 31, 2013

Conditions
Healthy
Interventions
DRUG

gemigliptin only

gemigliptin 50mg qd on day 1\~7

DRUG

rosuvastatin only

rosuvastatin 20mg qd on day 1\~7

DRUG

gemigliptin and rosuvastatin

gemigliptin 50mg, rosuvastatin 20mg qd on day 1\~7

Trial Locations (1)

Unknown

Asan Medical Center, Seoul

Sponsors

Lead Sponsor

LG Life Sciences
All Listed Sponsors
lead

LG Life Sciences

INDUSTRY